NEI Announces Participation in PA-11-347 "NINDS SBIR Technology Transfer (SBIR-TT [R43/R44])"

Notice Number: NOT-EY-13-004

Key Dates
Release Date: September 26, 2013

Related Announcements

Issued by
National Eye Institute (NEI)


This Notice is to inform potential applicants that the NEI announces its participation in PA-11-347, "NINDS SBIR Technology Transfer (SBIR-TT [R43/R44]).”  The NEI seeks SBIR applications for projects to transfer technologies out of the NIH intramural research labs into the private sector that address mechanisms, diseases, or disorders within the NEI mission.

  • Any project that fits within the NEI mission and relies on the use of an NIH intramural technology is eligible for this award. Please see the NEI Office of Technology Transfer and Development for more details on NEI licensing opportunities:  For a complete listing of NIH intramural technologies which are available, please see NIH Office of Technology Transfer at:
  • The NEI Division of Intramural Research performs high quality and innovative research in a variety of basic, translational, and clinical areas, including imaging, diagnostics, regenerative medicine, genetics/genomics, developmental biology, cellular and gene therapy, and cell and molecular biology related to vision disorders and diseases. For more information about the research and investigators in the NEI Division of Intramural Research, please see:
  • An NEI intramural investigator may provide assistance in a collaborative manner by providing technology, reagents and/or discussions during the SBIR award period; however, no SBIR funds are allowed to go to the NEI intramural investigator or the NEI intramural program.

The following sections of PA-11-347  have been updated to reflect the participation of NEI in this FOA.

Part 1. Overview Information

Components of Participating Organizations
National Heart, Lung, and Blood Institute (NHLBI
National Institute of Neurological Disorders and Stroke (NINDS)
National Eye Institute (NEI

Catalog of Federal Domestic Assistance (CFDA) Number(s)
93.853, 93.233, 93.837, 93.838, 93.839, 93.867

All other aspects of the FOA remain unchanged.


Please direct all inquiries to:

Jerome Wujek, Ph.D.
National Eye Institute (NEI)
Telephone: (301) 451-2020

Alan E. Hubbs, Ph.D.
National Eye Institute (NEI)
Phone: (240) 276-5532